Ribosome biogenesis programs define a three-gene RBscore with prognostic relevance in bladder cancer.

Saved in:
Bibliographic Details
Title: Ribosome biogenesis programs define a three-gene RBscore with prognostic relevance in bladder cancer.
Authors: Luo G; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China., Wang W; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China., Tai S; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China., Yan L; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China., Luo H; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China., Chang Y; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China., Yang L; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China., Yan J; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China., Zhou J; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China., Liang C; Department of Urology, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China.; Institute of Urology, Anhui Medical University, Hefei, Anhui, China.; Anhui Province Key Laboratory of Genitourinary Diseases, Anhui Medical University, Hefei, Anhui, China.
Source: Frontiers in immunology [Front Immunol] 2026 Apr 16; Vol. 17, pp. 1810132. Date of Electronic Publication: 2026 Apr 16 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1810132